Telmisartan Market To Witness Growth Owing To Increasing Prevalence Of Hypertension The Telmisartan Market is estimated to be valued at US$ 3567.30 Mn in 2023 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Telmisartan is an angiotensin II receptor antagonist used alone or in combination with hydrochlorothiazide for the treatment of hypertension or high blood...
0 aandelen
1069 Views
0 voorbeeld